Michael Gelband’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Michael Gelband’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-77,283	Closed	-$1.44M	–	2752
2022 Q1	$1.44M	Buy	77,283 +29,663	+62%	+$534K	0.02%	945
2021 Q4	$1.02M	Buy	47,620 +36,802	+340%	+$725K	0.01%	1059
2021 Q3	$200K	Sell	10,818 -21,113	-66%	-$425K	﹤0.01%	1785
2021 Q2	$684K	Buy	+31,931	New	+$649K	0.01%	1203

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Michael Gelband's OCDX Position: Q2 2022 in Review

Michael Gelband sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 77,283 shares — an estimated $1.44M sold.

Michael Gelband first reported a position in OCDX in Q2 2021 and held it in 4 quarters. The position peaked at $1.44M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Michael Gelband reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Michael Gelband sold 77,283 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $1.44M.
Michael Gelband first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2021 and held it in 4 quarters.
Michael Gelband's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.44M in Q1 2022.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.